FTC Stakes New Territory, Joins FDA In Warning On H1N1 Claims
This article was originally published in The Tan Sheet
Executive Summary
A warning letter sent jointly by FDA and the Federal Trade Commission takes a double-pronged approach toward cracking down on a supplement marketer's claims regarding the H1N1 flu virus